BREMEN, Germany—- Bruker today announces multiple placements of MALDI Biotyper systems for rapid, differentiated and cost-effective microbial identification with various local, state and federal authorities and institutes in Germany. These local authorities are responsible for public health, animal health, food safety, consumer protection, agriculture and fisheries. In recent years, European clinical laboratories have been increasingly […]
Appointment of permanent CEO The Board of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to announce that, further to the Company’s announcement dated November 28th, 2012, Ms. Alison Mew has been appointed as the permanent Chief Executive Officer of Genetic Technologies Limited. GTG Chairman, Dr. Mal Brandon said “The Board is extremely pleased that […]
Salem, NH, –ALPCO Diagnostics is pleased to announce their North American distribution agreement with Swedish assay development and manufacturing company Euro Diagnostica. As part of this agreement, ALPCO will have access to and distribute Euro Diagnostica’s comprehensive, high quality assay portfolio throughout North America. Products to note from this catalog include Euro Diagnostica’s gold standard […]
Agilent Technologies Inc. (NYSE: A) today announced its microarrays were used in a landmark prenatal research study published on Thursday in the New England Journal of Medicine. The three-year collaborative study, “Chromosomal microarray versus karyotyping for prenatal diagnosis,” represents a significant milestone in understanding prenatal abnormalities. Agilent SurePrint CGH microarrays were used for the majority […]
Today Roche Diagnostics and the US President’s Emergency Plan for AIDS Relief (PEPFAR) announced a public-private partnership to improve the capacity of laboratorians and strengthen laboratory systems in African nations highly impacted by HIV/AIDS. Valued at $12 million over five years, the goal of the partnership is to build institutional capacity of regional and national […]
SEATTLE & SAN ANTONIO — NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature. The study, which evaluated samples […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the U.S. Patent and Trademark Office will issue U.S. Patent No. 8,340,916 on December 25, 2012 with claims to novel methods for detecting fetal aneuploidy using massively parallel sequencing. The patent is entitled Diagnosing Fetal Chromosomal […]
LAKE OSWEGO, Ore. and NEWCASTLE-UPON-TYNE, United Kingdom, — Galena Biopharma, Inc. (Nasdaq:GALE) and Leica Biosystems today announced a partnership to develop a companion diagnostic for Galena’s NeuVax™ (nelipepimut-S or E75) breast cancer therapeutic. Galena Biopharma is a United States based biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to […]
LEXINGTON, MA – Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced that the Company has developed a new next-generation sequencing (NGS) assay for the TP53 gene (encoding the p53 protein) that will enhance the clinical performance of its bladder cancer assay. The new CertNDxTM Bladder Cancer Assay incorporating TP53 is expected to […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today provided an update to its November 5th announcement that the company was awarded a three-year sole source group purchasing contract for its blood bank reagents from the Premier healthcare alliance. Bio-Rad […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
